ESTA Founder Sells $7.9M on Earnings Day — Here's Why that's Not the Story
The founder and former CEO of Establishment Labs Holdings Inc. (ESTA), Juan José Chacón Quirós, indirectly sold 105,000 shares worth $7.92 million on May 6, 2026. This transaction was pre-scheduled under a 10b5-1 plan adopted in December 2025, making its timing on earnings day coincidental rather than an indicator of company performance. Investors should instead focus on the company's Q1 results, which show strong US revenue growth, positive adjusted EBITDA, and raised full-year guidance as key metrics for evaluating ESTA.
How this was made

The 30-second read
Why it matters
The sale was not motivated by negative company outlook but was routine; Q1 results are more indicative of company health.
Market read
While insider sales can sometimes signal caution, in this case, the routine nature and strong earnings suggest limited negative impact.
What to watch
Potential upcoming regulatory changes or market conditions that could affect ESTA's stock.
Background
Juan José Chacón Quirós, founder and ex-CEO, sold shares via a pre-scheduled plan, which is common among insiders to diversify holdings or meet personal financial needs.
Ticker impact
Primary focus due to recent insider transaction and strong Q1 results.
Minimal immediate impact; potential slight upward movement if Q1 results are better than expected.
Scheduled insider transactions under a 10b5-1 plan are routine and do not reflect company performance. Strong Q1 metrics support a positive outlook.
Market effects
Positive sentiment for life sciences and medical device sectors due to strong earnings.
Limited regional impact; company performance is primarily US-focused.
Moderate, as ESTA operates internationally but is primarily US-centric.
Counterpoint
Some traders might interpret the insider sale as a sign of upcoming dilution or internal concerns, warranting caution.
Key entities
- PersonJuan José Chacón Quirós
Founder and former CEO of ESTA.
- CompanyEstablishment Labs Holdings Inc.
Medical device company specializing in aesthetic and reconstructive products.

